Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children.
BACKGROUND:Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare...
Saved in:
Main Authors: | Gemma Louise Kay (Author), Andrew Millard (Author), Martin J Sergeant (Author), Nicholas Midzi (Author), Reggis Gwisai (Author), Takafira Mduluza (Author), Alasdair Ivens (Author), Norman Nausch (Author), Francisca Mutapi (Author), Mark Pallen (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children.
by: PLOS Neglected Tropical Diseases Staff
Published: (2015) -
Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011) -
Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children.
by: Laura J Appleby, et al.
Published: (2012) -
Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children.
by: Welcome M Wami, et al.
Published: (2015) -
Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
by: Kate M Mitchell, et al.
Published: (2014)